Paul Navarre

Chief Executive Officer

Paul Navarre is responsible for all Ferring US activities including commercial operations, clinical development and manufacturing.

Paul has more than 25 years of experience in the pharmaceuticals and consumer goods industries. Before joining Ferring in 2017, he was President of Allergan International where he managed a $3 billion specialty care business covering dermatology, ophthalmology, urology and neurosciences. Paul began his career in consumer goods at Procter & Gamble before moving to the company’s pharmaceutical division. During his 15 years at P&G, he held a positions of increasing responsibility in France, the USA, Switzerland, Italy and the UK.

Paul holds a Master of Business Administration degree from the ISC Paris Business School in Paris, France.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience.

©2008-2019 Ferring Pharmaceuticals.  US--1900006